Autopsy report · NCT04297839
Evaluation of Regional Anticoagulation With Citrate in Extended Hemodialysis
Cause of deathStaffing, sites or logistics
“DUE TO CORONAVIRUS DISEASE, ACTIVITIES INTHE HOSPITAL ARE SUPRESSED”
Life of this trial
- Registered 9 months after it had already started.
- Suspended: paused, and may or may not restart.
- 200 participants planned (an estimate, not an actual count).
Vital statistics
- Status
- Suspended
- Phase
- Phase 3
- Sponsor
- University of Sao Paulo General Hospital
- Sponsor type
- University, hospital or other
- Conditions
- Hemodialysis Complication; Acute Kidney Injury; Anticoagulant Toxicity
- Interventions
- Citrate Anticoagulation Solution; Control Group (heparin or continuous saline)
- Participants
- 200 (planned, not actual)
- Sites
- 1
- Countries
- Brazil
Trials that died the same way
- Comparison of Silver Diamine Fluoride and Sodium Fluoride Varnish to Prevent and Arrest Root Caries in Older Adults
“Coronavirus Pandemic”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.